| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.4M | — | +40.7% |
| Cost of Revenue | $6.1M | — | +19.2% |
| Gross Profit | $1.3M | — | +878.0% |
| R&D Expense | $1.0M | — | +27.2% |
| SG&A Expense | $3.1M | — | -0.7% |
| Operating Income | -$4.2M | — | +23.1% |
| Pre-tax Income | -$3.4M | — | +28.1% |
| Income Tax | $5K | — | +66.7% |
| Net Income | -$3.4M | — | +28.0% |
| EPS (Basic) | -$0.15 | — | +28.6% |
| EPS (Diluted) | -$0.15 | — | +28.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $124.5M | -3.2% | -5.9% |
| Accounts Receivable | $3.2M | -21.1% | -11.3% |
| Inventory | $8.9M | +20.1% | +14.9% |
| Current Assets | $138.9M | -2.6% | -6.6% |
| Total Assets | $147.6M | -2.4% | -7.0% |
| Current Liabilities | $9.3M | -0.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.8M | — | +13.6% |
| Investing Cash Flow | -$882K | — | -193.0% |
| Financing Cash Flow | -$350K | — | -107.1% |
| +28.9% |
| Total Liabilities | $10.5M | -1.4% | +27.3% |
| Stockholders' Equity | $137.2M | -2.5% | -8.9% |